Armata Pharmaceuticals, Inc. (ARMP) stock
ARMPNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.66−0.33 (-11.04%)
Close on Nov 17, 2026Market cap $98.90MP/E –Yield –
Armata Pharmaceuticals price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Armata Pharmaceuticals's price to sales ratio was 204.9× on Jul 31, 2015.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2015 | Jul 31, 2015 | 204.9× | – |
See a number that looks wrong?